Liliana Montella

Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance

Raffaele Addeo, Michele Caraglia, Sergio Bellini et al. · Journal of Clinical Oncology · 2009 · 190 citations

Medicine, Oncology, Pharmacology +13

Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib

Bruno Vincenzi, Daniele Santini, Antonio Russo et al. · The Oncologist · 2010 · 176 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Somatostatin analogs and prednisone in advanced refractory thymic tumors

Giovannella Palmieri, Liliana Montella, Angelo Martignetti et al. · Cancer · 2002 · 102 citations

Medicine, Oncology, Pharmacology +14

Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR

Michele Caraglia, G. Giuberti, Maurizio Marra et al. · Cell Death and Disease · 2011 · 97 citations · Full text

Medicine, Oncology, Pharmacology +17

Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer

Raffaele Addeo, Alessandro Sgambato, Gregorio Cennamo et al. · Clinical Breast Cancer · 2010 · 93 citations

Medicine, Oncology, Pharmacology +10